ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

DATATRAK ePRO/eCOA Solution Expands Decentralized Trial Platform

Device‑agnostic ePRO that is BYOD (bring your own device) with email/SMS reminders, patient portals, and unified reporting across EDC and eDiaries

AUSTIN, TX / ACCESS Newswire / March 10, 2026 / DATATRAK Powered by Fountayn, a unified eClinical and decentralized clinical trial (DCT) platform, today announced the availability of its enhanced electronic patient‑reported outcomes (ePRO) and eCOA solution, designed to help sponsors, CROs, and sites collect high‑quality patient data for hybrid and decentralized clinical trials. Built on DATATRAK's core eClinical platform, the ePRO module can be deployed as a standalone solution or tightly integrated with the DATATRAK EDC to support end‑to‑end digital trials.​​

DATATRAK ePRO is a device‑agnostic, true BYOD solution that allows patients to use their own smartphones, tablets, or computers, reducing study costs and barriers to participation. Study teams can configure eDiaries and electronic clinical outcome assessments (eCOA) using the same eCRF design toolkit they rely on for EDC casebooks, enabling faster start‑up and consistent design across all data capture tools.​

"Our customers want ePRO that is flexible, affordable, and fully connected to their EDC - not another silo," said Alex Tabatabai, CEO, DATATRAK Powered by Fountayn. "With DATATRAK ePRO, sponsors and CROs can design and launch eDiaries and eCOA quickly, send automated email and SMS reminders, and analyze compliance alongside EDC casebook data, all within a single, unified platform."​

Standalone ePRO or Fully Integrated with EDC

DATATRAK's ePRO solution is built on the same core platform as its EDC, RTSM, CTMS, eTMF, and eConsent tools. Customers can:​

  1. Use ePRO as a standalone product and integrate with third‑party EDC or clinical trial systems, or

  2. Add ePRO as a native extension of the DATATRAK EDC to create a unified environment for data capture, randomization, and trial operations.​​

Sites can invite and enroll ePRO participants directly from the EDC, link patient‑reported outcome data to subject records, and trigger one‑time notifications from within the EDC workflow. This tight integration helps reduce manual reconciliation and improves data quality across the study lifecycle.​

Patient Engagement Through Email/SMS and Secure Portal

To support patient engagement and compliance, DATATRAK ePRO includes:​

  1. Email and SMS notifications to remind participants when eDiary or eCOA entries are due

  2. A patient portal with secure PIN sign‑in so participants can easily access their tasks and forms

  3. Configurable one‑time notifications sent from the EDC to specific participants or cohorts

These communication tools help improve completion rates and provide sites with better visibility into participant status in real time.​​

Unified Reporting Across eDiaries and EDC

Flexible reporting tools span both EDC casebooks and eDiaries, enabling study teams to build compliance and performance reports that incorporate patient‑reported outcomes alongside other clinical data. This unified view supports better decision‑making, early signal detection, and streamlined preparation for data reviews and regulatory inspections.​

With databases hosted in key regions including the United States, Japan, and Europe -and options for additional local data hosting-DATATRAK Powered by Fountayn supports global studies while aligning with regional data privacy and security requirements.​​

About DATATRAK

Datatrak is transforming healthcare and life sciences through technological innovations from providing the first EDC technology to offering the first true eSource solution that seamlessly integrates all aspects of clinical trial data management including EDC, RTSM, RBM, eTMF, CTMS, ePRO, eConsent, Endpoint Adjudication, Imaging Data, Safety, Inventory Management, and Enterprise Management of Automated Alerts, Workflows, Documents, Timelines, and Global Oversight. No other company has been innovating in healthcare and life sciences as long as Datatrak. For over thirty years clinical trial professionals have trusted Datatrak for reliable and secure technology solutions. Datatrak complies with the highest Quality Assurance standards that are 21 CFR Part 11, GDPR, GCP, HIPAA, and CDISC compliant that are fully validated by our experienced team of software quality engineers. Datatrak's cloud-based platform is trusted in 83 countries, 6 continents, for over 10,000 clinical trials. Datatrak is based in Austin, Texas and has team members and data hosting infrastructure in its key service regions of the United States, Europe, and Japan. For more information, visit www.datatrak.com or www.fountayn.com.

Contact:

Sales Department
sales@fountayn.com

SOURCE: Datatrak International



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.04
-1.10 (-0.52%)
AAPL  253.23
+1.74 (0.69%)
AMD  202.88
+0.20 (0.10%)
BAC  48.05
+0.53 (1.12%)
GOOG  294.22
-4.80 (-1.61%)
META  598.00
-6.06 (-1.00%)
MSFT  376.13
-6.87 (-1.79%)
NVDA  175.27
-0.37 (-0.21%)
ORCL  149.20
-5.14 (-3.33%)
TSLA  386.79
+5.94 (1.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.